Tencent Explores AI Integration with DeepSeek in Weixin Super App
February 16, 2025 - 10:35
Tencent Holdings is currently testing the integration of DeepSeek's AI capabilities within its widely used Weixin super app. This move highlights Tencent's commitment to enhancing its services, which range from social networking to e-payments and ride-hailing, through advanced artificial intelligence technologies.
During the ongoing beta test, users can find an "AI Search" option in the Weixin search bar, allowing them to access DeepSeek's functionalities alongside Tencent's own Hunyuan foundational model. This integration aims to provide users with more efficient and intelligent search capabilities, making it easier to navigate the myriad services offered by the app.
While the feature is not yet available to all users, the testing phase signifies Tencent's strategic push into the AI domain, reflecting a broader trend among tech companies to leverage AI for improving user experience and service delivery. As the beta progresses, it will be interesting to see how this integration shapes the future of Weixin and its competitive edge in the market.
MORE NEWS
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...